https://biorelate.com https://biorelate.com/solutions/data-scientists https://biorelate.com/resources/news https://biorelate.com/company https://biorelate.com/use-cases/knowledge-graphs https://biorelate.com/solutions/biologists-bioinformaticians https://biorelate.com/solutions/information-managers-library-scientists https://biorelate.com/faq https://biorelate.com/resources/events https://biorelate.com/resources/webinars https://biorelate.com/use-cases/target-selection https://biorelate.com/use-cases/moa-and-explainability https://biorelate.com/use-cases/indication-expansion https://biorelate.com/use-cases/biomarker-selection https://biorelate.com/use-cases/knowledge-reviews https://biorelate.com/resources/downloads https://biorelate.com/request-a-demo https://biorelate.com/resources/knowledge-graphs-in-drug-discovery https://biorelate.com/solutions/biotech-innovators https://biorelate.com/careers https://biorelate.com/july-webinar https://biorelate.com/request-access https://biorelate.com/login-page https://biorelate.com/solutions/galactic-enterprise https://biorelate.com/privacy-policy https://biorelate.com/cookie-policy https://biorelate.com/pts-whitepaper https://biorelate.com/whitepaper-login-page https://biorelate.com/content-hub https://biorelate.com/post/accelerating-drug-discovery-innovation-via-advanced-data-science-solutions https://biorelate.com/post/astrazenecas-innovative-graph-as-a-service-and-generative-ai-models-is-this-the-future-of-data-science https://biorelate.com/post/biomedical-named-entity-recognition-navigating-the-complexities-of-biomedical-language-and-the-promise-of-large-language-models-llms https://biorelate.com/post/biorelates-year-in-review-2024--new-leadership-llm-innovation-and-expanding-possibilities-for-causal-targets https://biorelate.com/post/daniel-jamieson-awarded-the-princess-royal-silver-medal https://biorelate.com/post/foundations-for-change-a-framework-for-transforming-r-d-outcomes-with-ai https://biorelate.com/post/from-the-voices-of-pharma-data-strategists-festival-of-genomics-2025-key-takeaways https://biorelate.com/post/galactic-data-3-0-the-future-of-ai-for-r-d https://biorelate.com/post/gen-ais-real-opportunity-in-drug-development-as-a-smart-strategic-decision-aid-drug-discovery-today https://biorelate.com/post/genai-and-llms-to-potentially-revolutionise-drug-discovery---what-top-pharma-thought-leaders-have-to-say https://biorelate.com/post/genais-real-potential-in-biopharma-as-a-cross-function-r-d-assistant https://biorelate.com/post/generative-ai-for-drug-discovery-in-the-era-of-chatgpt-the-top-7-key-considerations-for-biopharma https://biorelate.com/post/how-to-improve-ai-and-large-language-model-outputs-to-enhance-drug-discovery-according-to-large-pharma-experts https://biorelate.com/post/improving-life-science-r-d-outcomes-with-ai https://biorelate.com/post/making-ai-work-for-drug-discovery-a-joined-up-approach https://biorelate.com/post/mapping-disease-signaling-a-case-study-of-roflumilasts-potential-in-non-cystic-fibrosis-bronchiectasis https://biorelate.com/post/pharmatimes-magazine-reflections-and-predictions-2024-and-2025 https://biorelate.com/post/reading-between-the-lines-challenges-in-biomedical-relationship-extraction-and-the-promise-of-llms https://biorelate.com/post/respected-pharma-data-science-pioneer-dr-ben-sidders-to-spearhead-biorelates-next-growth-phase-as-chief-scientific-officer https://biorelate.com/post/revolutionising-life-sciences-an-insightful-conversation-with-dr-ben-sidders https://biorelate.com/post/siloed-use-of-gen-ai-will-limit-its-transformation-potential https://biorelate.com/post/staying-ai-head-of-the-game https://biorelate.com/post/super-models-a-framework-to-optimise-r-d-success-with-ai-pharmatimes https://biorelate.com/post/the-festival-of-genomics-and-biodata-2024 https://biorelate.com/post/the-importance-of-data-quality-in-2025-according-to-pharma-leaders https://biorelate.com/post/the-limitations-of-named-entity-recognition-in-the-era-of-llms-nlp-and-text-mining-for-drug-discovery-the-case-study-of-p40 https://biorelate.com/post/the-promise-of-ai-for-addressing-pressing-drug-discovery-inefficiencies-according-to-large-pharma-experts https://biorelate.com/post/the-what-why-and-how-of-llms-in-drug-discovery---what-top-pharma-thought-leaders-have-to-say https://biorelate.com/post/unlocking-insights-the-imperative-of-structured-data-sets-from-unstructured-sources https://biorelate.com/post/unlocking-the-future-of-precision-oncology-with-knowledge-graphs https://biorelate.com/post/unlocking-the-power-of-data-in-ai-driven-drug-discovery https://biorelate.com/post/what-does-speed-to-cycle-mean-for-the-pharmaceutical-industry-and-why-does-it-matter-so-much https://biorelate.com/webinars/alex-ridden---knights-analytics---monitoring-commercial-developments-using-knowledge-graphs https://biorelate.com/webinars/an-ignorance-base-for-prenatal-nutrition-a-knowledge-graph-to-explore-the-literatures-known-unknowns https://biorelate.com/webinars/andre-freitas-university-of-manchester---industrial-scale-scientific-reasoning-encoding-abstract-natural-language-inference https://biorelate.com/webinars/andrea-splendiani-iqvia-beyond-r-d-experiences-in-bringing-knowledge-graphs-and-fair-beyond-their-comfort-zone-see-just-his-talk https://biorelate.com/webinars/ben-sidders---head-of-oncology-bioinformatics-at-astrazeneca---knowledge-graphs-for-drug-discovery https://biorelate.com/webinars/biorelate-introduction-nlp-curated-causal-data-knowledge-graph-construction-for-lung-cancer https://biorelate.com/webinars/building-causal-hypotheses-in-drug-discovery https://biorelate.com/webinars/cedric-berger---roche---walking-down-the-data-centric-ai-road-with-knowledge-graphs-at-your-side https://biorelate.com/webinars/daniel-jamieson---biorelate---cause-and-effect-to-empower-drug-discovery https://biorelate.com/webinars/dr-namshik-han---head-of-artificial-intelligence-at-milner-therapeutics-institute https://biorelate.com/webinars/dr-nikola-milosevic---computational-scientist-at-bayer-pharmaceuticals--moving-from-information-retrieval-to-knowledge-graphs https://biorelate.com/webinars/galactic-web-deep-literature-search-example-how-is-obesity-related-to-alzheimers-disease https://biorelate.com/webinars/how-to-get-the-best-out-of-rag-for-scientific-research https://biorelate.com/webinars/james-longden-e-therapeutics-kgidd8-talk https://biorelate.com/webinars/jim-webber-the-chief-scientist-at-neo4j-graph-data-science-and-graph-machine-learning-for-the-uniniated https://biorelate.com/webinars/jon-hill--boehringer-ingelheim--using-retrieval-augmented-generation-approaches-to-gather-information-for-drug-discovery https://biorelate.com/webinars/jon-stevens--abbvie-inc---ask-arch-llm-question-answering-over-large-scale-knowledge-graphs https://biorelate.com/webinars/jonny-wray-cto-at-e-therapeutics-network-driven-drug-discovery https://biorelate.com/webinars/jyothish-soman-the-director-of-engineering-at-relation-therapeutics---utilizing-graph-machine-learning-within-drug-discovery-and-development https://biorelate.com/webinars/knowledge-graphs-and-graph-neural-networks-for-early-drug-target-characterization https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p10 https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p10-full-conference-video https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p6-full-conference-video https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p7-full-conference-video https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p8-full-conference-video https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-p9-full-conference-video https://biorelate.com/webinars/knowledge-graphs-in-drug-discovery-part-5-full-conference-video https://biorelate.com/webinars/krishna-bulusu---knowledge-graphs-for-target-discovery-and-precision-oncology-at-astrazeneca https://biorelate.com/webinars/large-language-models-in-the-real-world-p2 https://biorelate.com/webinars/manasa-ramakrishna-astrazeneca-text-mined-information-and-its-usage-in-machine-learning-based-target-prediction https://biorelate.com/webinars/maria-chatzou-dunford---real-time-disease-surveillance-using-artificial-intelligence-lifebit-real https://biorelate.com/webinars/martin-immanuel-bittner-co-founder-ceo-of-arctoris-discussing-trends-in-biotech-and-the-emergence-of-data-driven-drug-discovery https://biorelate.com/webinars/mastering-llms-and-knowledge-graphs https://biorelate.com/webinars/miguel-goncalves--astrazeneca---multi-modal-knowledge-graphs-for-precision-oncology https://biorelate.com/webinars/natalie-romanov--merck-kgaa---leveraging-knowledge-graph-representation-of-data-for-fair-and-machine-learning-analytics https://biorelate.com/webinars/ozge-gurbuz---boehringer-ingelheim---knowledge-graphs-for-indication-expansion https://biorelate.com/webinars/samantha-dale-strasser--pepper-bio--transomics-ushering-in-a-new-era-of-drug-discovery https://biorelate.com/webinars/sergio-baranzini--ucsf--spoke-a-massive-biomedical-knowledge-graph-to-advance-precision-medicine https://biorelate.com/webinars/shameer-khader---astrazeneca-enabling-discovery-of-drug-targets-to-optimizing-clinical-trials-using-biomedical-big-data-and-knowledge-graphs https://biorelate.com/webinars/solving-common-drug-discovery-challenges-with-the-latest-artificial-intelligence-and-large-language-models https://biorelate.com/webinars/sophia-krix--fraunhofer-scai---adverse-event-prediction-with-multimodal-graph-neural-network https://biorelate.com/webinars/sylvain-costes---nasa-space-biology---open-science-effort-to-foster-space-exploration https://biorelate.com/webinars/tom-chittenden---bio-ai-health--exascale-causal-ai-computing-for-the-biomedical-sciences https://biorelate.com/webinars/tom-freeman---janssen--from-lab-data-to-graphs-pattern-finding-in-high-dimensional-data https://biorelate.com/webinars/tomas-sabat-stofsel-coo-vaticle-enabling-the-computational-future-of-biology https://biorelate.com/webinars/transforming-manual-data-curation-through-agentic-ai-and-llms-how-biorelates-galactic-ai-tm-will-power-the-future-of-drug-discovery https://biorelate.com/webinars/tunca-dogan---hacettepe-university---a-knowledge-graph-based-computational-system-for-heterogeneous-biomedical-data https://biorelate.com/webinars/vivek-das-m-sc-ph-d-senior-research-scientist-in-computational-biology-at-novo-nordisk-on-the-role-of-bioinformatics-in-present-era-of-high-throughput-biology-and-drug-discovery https://biorelate.com/downloads/case-study-how-galactic-web-has-helped-turbine-speed-up-literature-reviews-and-identify-evidence-to-validate-novel-hypotheses https://biorelate.com/downloads/cause-and-effect-data-for-metformin-and-kidney-cancer https://biorelate.com/downloads/drug-repurposing https://biorelate.com/downloads/enhancing-drug-development-success-through-strategic-focus-on-mechanism-of-action-and-explainability https://biorelate.com/downloads/exploring-roflumilasts-potential-in-non-cystic-fibrosis-bronchiectasis https://biorelate.com/downloads/galactic-ai-tm-introduction-brochure https://biorelate.com/downloads/galactic-ai-tm-introduction-brochure-2 https://biorelate.com/downloads/galactic-api-datasheet https://biorelate.com/downloads/galactic-data-datasheet https://biorelate.com/downloads/galactic-web-datasheet https://biorelate.com/downloads/indication-selection-for-mid-sized-pharma https://biorelate.com/downloads/introduction-to-galactic-ai-tm-for-target-selection https://biorelate.com/downloads/parkinsons-disease-case-study-indication-expansion-target-expansion-and-understanding-mechanism-of-action https://biorelate.com/downloads/putting-large-language-models-at-the-heart-of-galactic-ai-tm https://biorelate.com/downloads/return-on-investment-roi-using-advanced-cause-and-effect-data-curation https://biorelate.com/downloads/safety-toxicity-review https://biorelate.com/downloads/target-selection https://biorelate.com/downloads/using-cause-and-effect-knowledge-graphs-to-find-genetic-drivers-for-als https://biorelate.com/downloads/using-contextual-cause-and-effect-data-and-a-disease-knowledge-graph-to-explore-lung-cancer